Latest period
−$53.49M
YoY change
+250.5%
5Y CAGR
—
Peak year (2019)
−$5.01M
Latest annual
−$54.54M
Free Cash Flow history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: −$54.54M
Free Cash Flow growth chart for Climb Bio (CLYM) from 2019 to 2025
Latest: +250.5%
Free Cash Flow history table for Climb Bio (CLYM) from 2019 to 2025
| 2025 | −$54.54M | +250.5% | −$38.98M | ||
| 2024 | −$15.56M | -24.5% | +$5.04M | ||
| 2023 | −$20.60M | -44.9% | +$16.77M | ||
| 2022 | −$37.37M | +3.6% | −$1.30M | ||
| 2021 | −$36.07M | +155.9% | −$21.97M | ||
| 2020 | −$14.10M | +181.5% | −$9.09M | ||
| 2019 | −$5.01M | — | — |
- 2025−$54.54M+250.5%
- 2024−$15.56M-24.5%
- 2023−$20.60M-44.9%
- 2022−$37.37M+3.6%
- 2021−$36.07M+155.9%
- 2020−$14.10M+181.5%
- 2019−$5.01M—
Free Cash Flow values are taken from Climb Bio's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Climb Bio (CLYM)
Free Cash Flow for Climb Bio (CLYM): headline value −$53.49M · YoY +250.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow for Climb Bio (CLYM) came in at −$54.54M – surged 250.5% year-over-year.
The highest annual free cash flow of −$5.01M was reported in 2019. The lowest in the available history was −$54.54M in 2025.
Climb Bio Free Cash Flow by Year
Climb Bio Free Cash Flow 2025: −$54.54M
In 2025, Climb Bio reported free cash flow of −$54.54M, surged 250.5% from 2024. This figure represents the lowest annual value in the available history.
Climb Bio Free Cash Flow 2024: −$15.56M
Climb Bio free cash flow in 2024 was −$15.56M, declined 24.5% below 2023.
Climb Bio Free Cash Flow 2023: −$20.60M
2023's free cash flow for Climb Bio came in at −$20.60M, plunged 44.9% below 2022.
Climb Bio Free Cash Flow 2022: −$37.37M
Climb Bio posted free cash flow of −$37.37M in 2022, edged up 3.6% from 2021.
Climb Bio Free Cash Flow 2021: −$36.07M
Climb Bio free cash flow in 2021 was −$36.07M.
See more financial history for Climb Bio (CLYM).
Sector peers by Free Cash Flow
Healthcare peers of Climb Bio (CLYM), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $11.77B | |
| $8.97B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $11.77B
- $8.97B
- $8.10B
- $4.52B
Frequently asked questions
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation